Showing results (541-550 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|December 1, 1994
Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case reportL Oehler, E Reiter, J Friedl, et al.
Annals of Hematology|September 1, 1994
Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factorR Weide, J Heymanns, H Köppler, et al.
Annals of Hematology|July 1, 1995
In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) geneA P Stegmann, M W Honders, A Hagemeijer, et al.
Annals of Hematology|August 1, 1995
Modified antisense oligodeoxynucleotides against the splice acceptor site of tat do not inhibit in vitro hematopoietic colony growth in HIV-positive patientsR G Geissler, J Muth, A Maurer, et al.
Annals of Hematology|April 1, 1994
Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromesM Imamura, M Kobayashi, S Kobayashi, et al.
Annals of Hematology|October 1, 1995
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitorsA Casonato, E Pontara, A Bertomoro, et al.
Annals of Hematology|June 1, 1995
Long-term therapy with recombinant human erythropoietin (rHu-EPO) in progressing multiple myelomaF Silvestris, A Romito, P Fanelli, et al.
Annals of Hematology|June 1, 1993
Anti-Sa cold agglutinin of IgA class requiring plasma-exchange therapy as early manifestation of multiple myelomaA Pereira, R Mazzara, L Escoda, et al.
Annals of Hematology|August 1, 1993
Ubenimex in the treatment of acute nonlymphocytic leukemia in adultsA Urabe, Y Mutoh, H Mizoguchi, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Pageof 667